TATA HEALTH (01255) Reports 2023 Annual Results with HK$32.294 Million Loss Attributable to Owners, Turning from Profit to Loss Year-over-Year
Stock News
Sep 10
TATA HEALTH (01255) announced its 2023 annual results, reporting revenue of approximately HK$207.5 million, representing a year-over-year increase of about 43.5%. The company recorded a loss attributable to owners of HK$32.294 million, marking a shift from profit to loss compared to the previous year, with a loss per share of HK$0.13. According to the announcement, the loss was primarily attributed to the healthcare and online medical services business segments, which remain in a state of long-term losses and operational stagnation.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.